Results 131 to 140 of about 56,538 (251)
ACR Open Rheumatology, Volume 8, Issue 4, April 2026.Objective This systematic review documents the current status of extracorporeal membrane oxygenation (ECMO) use in patients with complications of rheumatologic diseases. Methods Following Preferred Reporting Items for Systematic Reviews and Meta Analyses 2020 guidelines, we conducted a systematic review of studies published from January 2019 to ...
Kari L. Falaas +3 more
wiley +1 more source
Drug Design, Development and Therapy, 2017 Cristina Guarnera, Placido Bramanti, Emanuela Mazzon IRCCS Centro Neurolesi “Bonino-Pulejo”, Messina, Italy Abstract: In the therapeutic scenario of disease-modifying therapies for relapsing–remitting multiple sclerosis, the ...
Guarnera C, Bramanti P, Mazzon E
doaj
Clinical outcome of relapsing remitting multiple sclerosis among Hong Kong Chinese [PDF]
, 2010 PosterBACKGROUND: Many relapsing remitting multiple sclerosis (RRMS) patients develop irreversible progressive neurological disability. Reported clinical outcome varied. We aimed to study clinical outcome of Chinese RRMS patients.
Chan, KH +7 more
core
Diffuse and Prolonged Bone Pain Revealing Tumor‐Induced Osteomalacia: A Case Report
Clinical Case Reports, Volume 14, Issue 4, April 2026.ABSTRACT Tumor‐induced osteomalacia should be considered in patients with unexplained bone pain and fractures. Advanced imaging, such as Ga68‐DOTATATE PET/CT, enables precise tumor localization, and surgical excision can rapidly normalize phosphate metabolism and resolve symptoms, underscoring the importance of early diagnosis and intervention.
Rahman Amraei +3 more
wiley +1 more source
Gray matter structural correlates of fatigue in multiple sclerosis [PDF]
, 2016 We aimed to assess whether frontal cortex-striatum-thalamus (FCST) pathway or other grey matter (GM) structures are associated with longitudinal patterns of fatigue, namely reversible (RF) versus sustained fatigue (SF).
Nazeri, Aria
core +1 more source
Brain Age Estimation on T2‐FLAIR Scans for Application to Multiple Sclerosis
Human Brain Mapping, Volume 47, Issue 5, 1 April 2026.While the brain‐age paradigm has emerged as a promising biomarker of neurodegeneration in multiple sclerosis (MS), most available brain‐age prediction models are based on 3D‐T1w scans, which are not acquired in routine clinical practice. Leveraging a large multicentre collection of scans from healthy controls, we developed an accurate brain‐age ...
Jordan Colman +46 more
wiley +1 more source
Is it time to target no evident disease activity (NEDA) in multiple sclerosis? [PDF]
, 2015 Banwell +25 more
core +1 more source
MedComm, Volume 7, Issue 4, April 2026.This study evaluates the expression of microRNAs (miRNAs) in three distinct immune subsets (CD14+ monocytes, neutrophils, and CD8+ T cells) in multiple sclerosis and type 1 diabetes, reporting the presence of unique alteration patterns. Our integrative multi‐omics analysis suggests that miRNAs play a pivotal role in the differentiation and migration of
Jacopo Ronchi +11 more
wiley +1 more source
MedComm, Volume 7, Issue 4, April 2026.CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley +1 more source
Manufacturing and clinical applications of non‐CAR‐T immune effector cells
Transfusion, EarlyView.
Thane Kubik +2 more
wiley +1 more source